VKTX – viking therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

VKTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/19

09:07 am

vktx

Here's Why VKTX Stock Plummeted 18% on Wednesday [Yahoo! Finance]

Medium Report

Here's Why VKTX Stock Plummeted 18% on Wednesday [Yahoo! Finance]

Report

12/19

08:15 am

vktx

Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth [Yahoo! Finance]

Medium Report

Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth [Yahoo! Finance]

Report

12/18

10:19 am

vktx

Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.

Medium Report

Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.

Report

12/17

11:45 am

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

12/16

02:30 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

12/16

04:32 am

vktx

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 [Yahoo! Finance]

Low Report

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 [Yahoo! Finance]

Report

12/15

12:00 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

12/15

07:53 am

vktx

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street [Yahoo! Finance]

Low Report

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street [Yahoo! Finance]

Report

12/13

07:34 pm

vktx

Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know [Yahoo! Finance]

Low Report

Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know [Yahoo! Finance]

Report

12/13

01:45 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

12/13

01:45 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

12/13

01:30 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

12/11

02:30 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

12/3

07:23 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

12/3

08:34 am

vktx

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now? [Yahoo! Finance]

Low Report

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now? [Yahoo! Finance]

Report

12/2

08:06 am

vktx

Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $74.00 price target on the stock.

Medium Report

Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $74.00 price target on the stock.

Report

11/27

12:00 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

11/26

04:30 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

11/26

12:30 pm

vktx

Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.

Low Report

Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.

Report

11/25

08:05 pm

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Medium Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

11/25

04:27 am

vktx

Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst [Yahoo! Finance]

Low Report

Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst [Yahoo! Finance]

Report

11/23

06:46 am

vktx

Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at B. Riley to a "strong-buy" rating.

Low Report

Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at B. Riley to a "strong-buy" rating.

Report

11/22

12:49 pm

vktx

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report? [Yahoo! Finance]

Low Report

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report? [Yahoo! Finance]

Report

11/22

11:00 am

vktx

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Low Report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX

Report

11/22

08:29 am

vktx

Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at B. Riley. They set a "buy" rating and a $109.00 price target on the stock.

Low Report

Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at B. Riley. They set a "buy" rating and a $109.00 price target on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.